...
首页> 外文期刊>World Journal of Gastroenterology >Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma
【24h】

Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma

机译:脾切除术在肝癌肝切除术中对肝细胞癌的影响

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular circinoma. METHODS: Twenty-six patients with HCC associated with cirrhosis were divided into hepatectomy with splenectomy group (splenectomy group, n=11) and hepatectomy without splenectomy group (non-splenectomy group, n=15). T lymphocyte subsets such as CD4, CD8, CD4/CD8, helper T (Th) lymphocyte cytokines such as interferon γ(IFN-γ), interleukin 2(IL-2), interleukin 10(IL-10) and white blood cell (WBC), platelet (PLT), total bilirubin (T-Bil) were measured and used as parameters to evaluate the effects of splenectomy. RESULTS: There was no significant difference in CD4, CD8, CD4/CD8, IL2, IFN-γ, IL10, WBC, PLT, T-Bil levels between two groups before surgery. Two months after operation, the levels of CD4 (41.2%+-4.2 % vs 34.7%+-3.8%), CD4/ CD8 (1.7+-0.2 vs 1.0+-0.2), IFN-γ (102.3+-15.9 pg/ml vs 86.5+-14.8 pg/ml), IL-2(97.2+-15.6 pg/ml vs 77.6+-14.5 pg/ml) were increased and those of CD8 (25.6+-3.9 vs 32.8%+-4.1%), IL-10 (56.9+-10.4 pg/ml vs 72.6+-15.3 pg/ml) were decreased in splenectomy groups as compared with those in non-splenectomy group (P<0.05). WBC and PLT counts in the splenectomy group were 8.9+-1.6x10~9 and 310+-32x10~9, respectively, which were significantly higher than those in non-splenectomy group (3.7+-1.4x10~9 and 104+-41x10~9) respectively on the 14th post-operative day. T-Bil concentration in the splenectomy group (24+-7 μmol/L) was significantly lower than that in the non-splenectomy group (37+-13 μmol/L) on the 7th post-operative day (P<0.05). CONCLUSION: Splenectomy combined with hepatectomy for HCC associated with cirrhosis is helpful for the recovery of T-lymphocyte subsets and the maintenance of Th1/Th2 cytokine balance.
机译:目的:研究脾切除术在肝切除肝硬化性肝细胞瘤患者中的作用。方法:26例肝硬化合并肝癌患者分为脾切除术组肝切除术(脾切除术组,n = 11)和无脾切除术组肝切除术(非脾切除术组,n = 15)。 T淋巴细胞亚群(例如CD4,CD8,CD4 / CD8),辅助性T(Th)淋巴细胞细胞因子,例如干扰素γ(IFN-γ),白介素2(IL-2),白介素10(IL-10)和白细胞(测量WBC),血小板(PLT),总胆红素(T-Bil),并将其用作评估脾切除术效果的参数。结果:两组患者术前CD4,CD8,CD4 / CD8,IL2,IFN-γ,IL10,WBC,PLT,T-Bil水平无明显差异。手术两个月后,CD4(41.2%+-4.2%vs 34.7%+-3.8%),CD4 / CD8(1.7 + -0.2 vs 1.0 + -0.2),IFN-γ(102.3 + -15.9 pg / ml(vs 86.5 + -14.8 pg / ml),IL-2(97.2 + -15.6 pg / ml vs 77.6 + -14.5 pg / ml)增加和CD8(25.6 + -3.9 vs 32.8%+-4.1%)与非脾切除组相比,脾切除组的IL-10(56.9±-10.4 pg / ml vs 72.6±-15.3 pg / ml)降低(P <0.05)。脾切除组的WBC和PLT计数分别为8.9 + -1.6x10〜9和310 + -32x10〜9,显着高于非脾切除组(3.7 + -1.4x10〜9和104 + -41x10 〜9)分别在术后第14天。术后第7天,脾切除组的T-Bil浓度(24 + -7μmol/ L)明显低于非脾切除组(37 + -13μmol/ L)(P <0.05)。结论:脾切除联合肝切除治疗肝硬化合并肝癌有助于恢复T淋巴细胞亚群和维持Th1 / Th2细胞因子平衡。

著录项

  • 来源
    《World Journal of Gastroenterology》 |2003年第11期|p.2460-2463|共4页
  • 作者单位

    Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 消化系及腹部疾病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号